1. Introduction {#sec1}
===============

Tilapia is one of the most important species of farmed fish of freshwater aquaculture in China. In recent years, disease caused by *Streptococcus agalactiae* has become a major challenge for the culture of tilapia, resulting in massive losses for tilapia farmers all over the world ([@bib9]). Probiotics (especially antagonistic probiotics) can reduce pathogenic bacteria by competitive exclusion, provide nutrients and enzymes to promote host growth, enhance the immune response by immune stimulation, and do not cause secondary pollution problems. In view of this, obtaining *S. agalactiae* antagonizing probiotics suitable for tilapia culture is of great practical significance for improving the resistance of tilapia and reducing the use of antibiotics.

Consumption of probiotics is an effective and attractive way to modulate the intestinal microbial composition and to maintain and promote host health ([@bib15]). The major mechanisms of action of probiotics include enhancement of epithelial barrier function, improved adhesion to intestinal cells and pathogen inhibition by occupying adhesion sites, production of antibacterial substances, and regulation of the immune function ([@bib44]). Through the above mechanisms, the purpose of regulating intestinal microbes and inhibiting the growth of pathogens is achieved ([@bib6]). Recently, the application of beneficial bacteria in the form of probiotics has been demonstrated to be useful in aquaculture ([@bib38]). The main probiotic microorganisms used in aquaculture include species belonging to the lactic acid bacteria (LAB) ([@bib10], [@bib28], [@bib31]) and *Bacillus* spp. ([@bib12], [@bib19], [@bib21], [@bib52]).

According to the results of previous studies, due to the beneficial properties of enhancing the immune system, competitive exclusion, and producing antibacterial substances, some *Bacillus* spp. (including *Bacillus subtilis*) have been frequently used as probiotics in aquaculture ([@bib7], [@bib30], [@bib55]). *Bacillus subtilis* probiotic candidates stimulated immune responses both locally and systemically in tilapia ([@bib16]) and effectively enhanced the growth performance and disease resistance of Nile tilapia ([@bib29]). In addition, both *B*. *subtilis* and *Bacillus cereus* promote intestinal colonization and improve survival rate (SR) without negatively influencing feed intake, total biomass, gross revenue, partial operating costs and net revenue of tilapia ([@bib35]). As a feed additive, the skin beneficial bacterial composition is promoted by the use of *Bacillus* spp., which can outcompete intestinal pathogenic bacteria ([@bib13]). Moreover, *B. subtilis* boosted the growth and vitality of beneficial LAB in the intestine of hosts ([@bib22]). *Bacillus* could prove to be effective for integrated prevention and control of streptococcosis infections ([@bib58]).

In this study, *B*. *cereus* was extracted from healthy Nile tilapia feces ([@bib28]), and *B. subtilis* was isolated from a mixed-species *Bacillus* spp. probiotic that was used for the regulation of aquaculture water quality in our lab ([@bib27]). Our previous study indicated that both strains were effective at antagonizing *S. agalactiae* in vitro ([@bib27], [@bib33]), but it is not clear whether they have a probiotic effect in vivo. This study assessed the effects of the potential probiotic strains with special antagonistic activity in Nile tilapia. Comprehensive evaluation of the effects on growth, survival, immunity, disease resistance and the intestinal microbiota provides a solid theoretical basis for subsequent commercialization and application of the potential probiotic strains.

2. Materials and methods {#sec2}
========================

All animal work in this paper was conducted according to relevant national and international guidelines. All animal care and experimental procedures were approved by the Committee on Animal Care and Use and the Committee on the Ethic of Animal Experiments of Chinese Academy of Fishery Sciences.

2.1. Bacteria and feed preparation {#sec2.1}
----------------------------------

The probiotic *B*. *cereus* NY5 and *B. subtilis* were identified based on morphological, physiological, and biochemical characteristics, as well as 16S rRNA gene sequencing. The bacteria were frozen in 50% glycerol and stored at −80 °C. The antagonistic experiments showed significant inhibition zones to *S. agalactiae* in vitro. Luria Broth (LB) liquid medium (OXOID), which had been centrifuged at 5,000 × *g* (Beckman Coulter, AK, USA) for 4 min, was used to culture *Bacillus* strains for 24 h at a temperature of 37 °C. Distilled water was used to wash the pellets twice, and these pellets were then lyophilized and suspended in phosphate-buffered saline (PBS) (1.8 mmol/L KH~2~PO~4~, 10.1 mmol/L NaH~2~PO~4~, 2.7 mmol/L KCl and 137 mmol/L NaCl, pH 7.4). A spread plate technique was used to determine viable cells according to the cell concentrations measured at OD600, which was linearly proportional to the number of viable cells in the suspension. All cell suspension OD600 values were adjusted to an adequate value (CFU/mL) for further experiments.

The formulation and the main ingredients of the basal diet are shown in [Table 1](#tbl1){ref-type="table"}. The experimental tilapia were given the probiotics, which were added in the basal diet at a dosage of 1 × 10^8^ CFU/g, as described in a previously conducted experiment using *Bacillus* spp. in tilapia culture ([@bib7], [@bib57]). The tilapia fed a pure basal diet were considered the experimental control check (CK) group. There were 3 kinds of diets prepared for the experiment: the basal diet with 1 × 10^8^ CFU/g of *B. subtilis* (BS group), the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5 (BC group), or the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *B. cereus* NY5 (BS + BC group). The preparation of these experimental diets followed the same process described in our previous study ([@bib60]). Briefly, powdered dietary ingredients were thoroughly mixed by hand, then blended with oil and water, and suitable *Bacillus* spp. cells were added to form a soft dough. To ensure the viability of the added probiotics, the diets were freshly prepared every day and kept sealed in plastic bags that were stored at 4 °C.Table 1Formulation and calculated chemical compositions of the basal diet.Table 1ItemContent, %Ingredients Fish meal48 Soybean meal22 Wheat flour25 Adhesives0.2 Soybean oil2.0 Ca(H~2~PO~4~)~2~2.0 Vitamin C phosphate ester0.1 Choline chloride (50%)0.3 Vitamin premix[1](#tbl1fn1){ref-type="table-fn"}0.2 Mineral premix[2](#tbl1fn2){ref-type="table-fn"}0.2Calculated chemical compositions Crude protein42.0 Crude lipid7.3 Ash9.5 Crude fibre3.1 N free extract27.9[^1][^2]

2.2. Fish and rearing conditions {#sec2.2}
--------------------------------

All experimental juvenile tilapia were provided by the Gaoyao Fish Farm of the Pearl River Fisheries Research Institute (Guangzhou, China), and ethyl 3-aminobenzoate methanesulfonate (MS-222) was used to anaesthetize the fish when necessary. Healthy juvenile tilapia were selected and acclimated in 750-L tanks for 2 wk from 28 to 29 °C under laboratory conditions and were fed the basal diet. Thereafter, fish that were eating normally, disease-free, non-injured and smaller-sized (0.20 ± 0.05 g) were randomly distributed into twelve 50-L tanks on a random basis with 60 tilapia in each tank and 3 replicates for each treatment. The adopted feeding cycle was determined on the basis of previous reports ([@bib57], [@bib60]). Every day for the next 6 wk, the tilapia were fed twice (at 09:00 and 16:00) until they were apparently satiated. Then, the basal diet was used to feed all of the tilapia for another week. The conditions of culture were identical to the description of [@bib60], and a 50% water exchange was carried out daily.

2.3. Growth performance and sampling {#sec2.3}
------------------------------------

After the 6-wk rearing period, tilapia were processed after 24 h of starvation and exposure to an excessive dosage 200 mg/L of MS-222 and were then counted and weighed. Samples were collected and processed as described in our previous study ([@bib60]). The midguts (approximately 1 cm) of 6 fish or 3 fish in each group were used for intestinal mucosal morphology investigation and reverse transcription-polymerase chain reaction (RT-PCR). The midguts of 3 fish in each group were randomly selected for gut bacteria detection by high-throughput sequencing. The calculations of various indicators, including the feed conversion ratio (FCR), weight gain (WG) and the SR, were conducted as previously described ([@bib42]).

2.4. Genomic DNA isolation {#sec2.4}
--------------------------

DNA was extracted from fish midgut samples using the DNeasy Blood & Tissue Kit (Qiagen, Venlo, The Netherlands) according to the manufacturer\'s protocol, with some modifications ([@bib19]).

2.5. Illumina high-throughput sequencing of barcoded 16S rRNA genes {#sec2.5}
-------------------------------------------------------------------

Illumina MiSeq library preparation and next-generation sequencing were conducted at GENEWIZ, Inc. (Suzhou, China). A Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA, USA) was used to quantify all of the DNA samples. Then, a MetaV Library Preparation kit (GENEWIZ, Inc., South Plainfield, NJ, USA) was used to generate amplicons with 30 to 50 ng of DNA. The selection of prokaryotic 16S rDNA\'s V3 and V4 hypervariable regions was performed to generate amplicons and conduct the ensuing taxonomic analysis ([@bib33]). Subsequent processing and analysis methods were based on our published protocols ([@bib60]).

2.6. Changes in gut microbiota after reverting to the basal diet for 1 wk {#sec2.6}
-------------------------------------------------------------------------

Sampling of the tilapia mid-intestine was conducted at each treatment (which contained 3 tilapia) 7 d after the fish were cut off the probiotic supply to assess the persistence of the intestinal probiotics via high-throughput sequencing analyses.

2.7. Intestinal histology {#sec2.7}
-------------------------

After 6 wk, transmission electron microscope (TEM) imaging and scanning electron microscopy (SEM) imaging were conducted on the mid-intestines of the 6 tilapia in each treatment group following the same operation as our recent study ([@bib60]).

2.8. Intestinal c-type lysozyme gene expression {#sec2.8}
-----------------------------------------------

After 6 wk, tilapia intestinal tissues were harvested for determination of c-type lysozyme (*lyzc*) expression. Protocols for total RNA extraction of the mid-intestine, RT-PCR and quantitative polymerase chain reaction (qPCR) were consistent with our previous study ([@bib60]). The target and reference genes used in this study were based on published information ([@bib40]). The following oligonucleotides were used for *lyzc* amplification: F-5′-AAGGGAAGCAGCAGCAGTTGTG-3′ and R-5′-CGTCCATGCCGTTAGCCTTGAG-3′. The gene encoding β-actin was chosen as the internal standard with the following primers: F-5′-CAGGGAGAAGATGACCCAGA-3′ and R-5′-CAGGGCATAACCCTAGTAGA-3′.

2.9. *Challenge with* S. agalactiae {#sec2.9}
-----------------------------------

Six weeks later, 25 fish from each replicate (including the CK group) were injected intraperitoneally with 20 μL of pathogenic *S. agalactiae* (WC1535) (median lethal dose \[LD~50~\] = 1 × 10^5^ CFU/mL), which was provided by our lab (Key Laboratory of Tropical & Subtropical Fishery Resource Application & Cultivation, Pearl River Fisheries Research Institute of Chinese Academy of Fishery Sciences \[CAFS\]) ([@bib60]). This strain was incubated at 37 °C for 48 h under anaerobic conditions in Brain Heart Infusion (BHI) media. The cultures were centrifuged (Beckman Coulter, AK, USA) at 2,000 × *g* for 5 min. The pellets were washed twice with PBS (130 mmol/L NaCl, 10 mmol/L NaH~2~PO~4~, pH 7.2). The number of bacterial cells in each suspension was determined by turbidimetry. Injected fish were monitored for clinical signs, postmortem lesions and daily mortalities for 2 wk.

2.10. Statistical analysis {#sec2.10}
--------------------------

Average values ± standard deviation (SD) were used to express the experimental results. Data were analyzed by one-way analysis of variance (ANOVA) with a Duncan\'s multiple range test. All analyses were conducted with SPSS 17.0 (SPSS, Inc.), and differences at *P* \< 0.05 were considered significant.

3. Results {#sec3}
==========

3.1. Growth performance and survival {#sec3.1}
------------------------------------

After the 6-wk feeding trial, there were greater WG values in the BS + BC and BC groups compared with the CK group (*P* \< 0.05) ([Table 2](#tbl2){ref-type="table"}). The FCR in the BC and BS + BC groups were lower compared to the CK group (*P* \< 0.05). No significant differences were identified for WG and FCR between the CK and BS groups (*P* \> 0.05). In addition, the tilapia in each group barely showed any significant differences in SR (*P* \> 0.05).Table 2Growth performance of tilapia fed diets supplemented with *Bacillus subtilis* and/or *Bacillus cereus* for 6 wk.[1](#tbl2fn1){ref-type="table-fn"}Table 2ItemGroups[2](#tbl2fn2){ref-type="table-fn"}CKBSBS + BCBCIBW, g0.20 ± 0.020.20 ± 0.020.19 ± 0.020.20 ± 0.02WG, %2,595.69 ± 229.91^a^2,772.65 ± 229.21^a^3,527.77 ± 359.08^b^3,532.20 ± 403.43^b^FCR1.39 ± 0.05^b^1.33 ± 0.07^b^1.07 ± 0.04^a^1.04 ± 0.02^a^SR, %94.07 ± 6.1291.11 ± 2.2289.63 ± 2.3193.33 ± 2.94[^3][^4][^5][^6]

3.2. Intestinal histology {#sec3.2}
-------------------------

Compared with the CK group, the tilapia fed probiotic-supplemented feed had longer and denser intestinal microvilli (*P* \< 0.05) ([Fig. 1](#fig1){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}).Fig. 1Electron microscope images of the gut microvilli. (A) Scanning electron microscopy (SEM) images for microvilli density; (B) transmission electron microscope (TEM) images of the microvilli length. CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5.Fig. 1Table 3Intestinal microvilli density and length of Nile tilapia fed diets supplemented with *Bacillus subtilis* or/and *Bacillus cereus* for 6 wk.[1](#tbl3fn1){ref-type="table-fn"}Table 3ItemGroups[2](#tbl3fn2){ref-type="table-fn"}CKBSBS + BCBCDensity, count/μm[2](#tbl3fn2){ref-type="table-fn"}85.66 ± 7.45^a^140.11 ± 13.19^bc^128.82 ± 7.83^b^142.76 ± 12.70^c^Length, μm0.91 ± 0.06^a^1.03 ± 0.03^c^1.00 ± 0.03^b^1.00 ± 0.03^b^[^7][^8][^9]

3.3. Expression of intestinal c-type lysozyme gene {#sec3.3}
--------------------------------------------------

As shown in [Fig. 2](#fig2){ref-type="fig"}, the expression of intestinal *lyzc* in the probiotic-fed groups was higher compared with the CK group (*P* \< 0.05), and the BC group had the highest level of *lyzc* gene expression.Fig. 2Levels of c-type lysozyme (*lyzc*) mRNA in the intestine of tilapia after 6 wk of feeding (*n* = 3). Data represent means ± SD. CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5. Means sharing a common superscript letter were not significantly different (*P* \> 0.05).Fig. 2

3.4. Challenge test {#sec3.4}
-------------------

[Fig. 3](#fig3){ref-type="fig"} presents the effects of probiotics on WC1535 resistance in tilapia. According to the results, each group had the highest daily mortality rate on the first day. Cumulative mortality was significantly lower in the BC (48%) and BS + BC (43%) groups compared to the CK (81.33%) and BS (85.33%) groups (*P* \< 0.05).Fig. 3Mortalities (means ± SD) of tilapia challenged by injection of *Streptococcus agalactiae* after being administered either the basal diet or the basal diet supplemented with probiotics for 6 wk. Data represent means ± SD. CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5. Different letters indicate significant differences (*P* \< 0.05).Fig. 3

3.5. High-throughput sequencing analysis {#sec3.5}
----------------------------------------

A tilapia gut microbiome analysis was conducted using high-throughput 16S rDNA deep sequencing technology (V3 and V4 regions). A total of 1,474,410 unique reads (average length 444 bp) were produced from 2,040,419 raw reads, and 189 operational taxonomic units (OTU) were identified from the gut DNA samples. The evaluation of the sample relationships was conducted on the basis of the different OTU phylogenetic diversities. As a result, the sequencing coverage (\> 0.90) was sufficient for all the treatments, which indicated the representativeness of the sample OTU.

Analyses were conducted on the indices of bacterial diversity and richness from the proportion of the OTU for the calculation of each experimental group\'s bacterial diversity ([Table 4](#tbl4){ref-type="table"}). The BC group had a lower species richness (Chao1 and ace) in comparison with the CK group (*P* \< 0.05). Upon cessation of probiotics for 1 wk, compared with the BS group, the BS group after cessation of probiotic consumption for 1 wk (BS-7D group) had higher Shannon and Simpson indices (*P* \< 0.05). In comparison with the BS + BC group, the BS + BC group after cessation of probiotic consumption for 1 wk (BS + BC-7D group) had lower ace and Chao1 indices (*P* \< 0.05). However, there was no significant difference in bacterial richness or diversity between the BC group and the BC group after cessation of probiotic consumption for 1 wk (BC-7D group) (*P* \> 0.05). The replicates in the BS and CK groups were closely clustered, while clearly separated from those in the other groups, which all clustered closely in the principal component analysis (PCoA) plot and non-metric multidimensional scaling (NDMS) diagram ([Fig. 4](#fig4){ref-type="fig"}).Table 4Richness and diversity statistics of the samples.[1](#tbl4fn1){ref-type="table-fn"}Table 4Group[2](#tbl4fn2){ref-type="table-fn"}AceChao1ShannonSimpsonGood\'s_coverageCK54.89 ± 5.26^bc^57.29 ± 3.71^c^1.18 ± 0.16^ab^0.32 ± 0.08^a^0.95 ± 0.02BS59.61 ± 5.84^c^58.83 ± 5.71^c^1.85 ± 0.47^ab^0.45 ± 0.11^a^0.96 ± 0.01BS + BC67.58 ± 8.85^c^69.17 ± 6.93^c^1.94 ± 0.27^b^0.50 ± 0.08^a^0.95 ± 0.03BC37.06 ± 3.74^a^36.44 ± 3.09^ab^1.16 ± 0.18^a^0.31 ± 0.07^a^0.98 ± 0.02BS-7D63.13 ± 5.94^c^62.78 ± 4.88^c^2.85 ± 0.29^c^0.74 ± 0.07^b^0.95 ± 0.05BS + BC-7D48.29 ± 3.46^b^47.72 ± 4.44^b^1.74 ± 0.30^ab^0.46 ± 0.06^a^0.97 ± 0.01BC-7D29.29 ± 2.64^a^27.67 ± 3.88^a^1.47 ± 0.13^ab^0.40 ± 0.03^a^0.95 ± 0.05[^10][^11][^12]Fig. 4Comparison of autochthonous intestinal microbiota composition between fish fed different diets. (A) Principal component (PC) analysis; (B) Non-metric multidimensional scaling (NMDS) diagram. CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5; BS-7D group: the BS group after cessation of probiotic consumption for 1 wk; BS + BC-7D group: the BS + BC group after cessation of probiotic consumption for 1 wk; BC-7D group: the BC group after cessation of probiotic consumption for 1 wk.Fig. 4

The composition of major bacteria at the phylum level in the intestines of fish fed different diets is shown in [Fig. 5](#fig5){ref-type="fig"}. In general, the most abundant phylum in the BS + BC and BC groups (accounting for 83.78% and 99.02% of 16S reads, respectively) was Proteobacteria, whereas the CK and BS groups were dominated by Fusobacteria (82.35% and 73.59%, respectively). The average amount of Proteobacteria and Bacteroidetes in the CK group (12.37% and 3.92%, respectively), Proteobacteria, Bacteroidetes, Actinobacteria, Firmicutes and Verrucomicrobia in the BS group (17.05%, 1.73%, 2.16%, 4.05% and 1.78%, respectively), and Fusobacteria, Actinobacteria and Chloroflexi in the BS + BC group (5.18%, 3.21% and 6.40%, respectively) were all above 1%. Saccharibacteria and Cyanobacteria were also present with relative abundances below 1% in the samples. Seven days after the probiotic supply was ceased, the Proteobacteria reads in BS group increased from 17.05% to 65.61%, while Fusobacteria reads dropped from 73.59% to 21.22%. The Fusobacteria and Proteobacteria reads in the BS + BC-7D (90.52% and 6.71%) and BC-7D groups (99.1% and 0.21%) were similar to those in the BS + BC and BC groups, which were 83.78% and 5.18% in the BS + BC group and 99.02% and 0.32% in the BC group, respectively.Fig. 5Taxonomic distribution of gut samples at the phylum level. CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5; BS-7D group: the BS group after cessation of probiotic consumption for 1 wk; BS + BC-7D group: the BS + BC group after cessation of probiotic consumption for 1 wk; BC-7D group: the BC group after cessation of probiotic consumption for 1 wk.Fig. 5

*Rhizobium* was found at a significant greater proportion (58.78% and 82.26%, respectively) in the BS + BC and BC groups and was also detected in the intestines of tilapia of BS and CK groups, yet it was higher in the former 2 groups ([Fig. 6](#fig6){ref-type="fig"}). *Cetobacterium* was the predominant genus (accounting for 82.35% and 73.53% of reads) in CK and BS groups; however, it was found much less frequently in the BS + BC and BC groups (4.18% in BS + BC group and 0.32% in BC group). Reads of *Phyllobacterium*, one of the major genera that accounted for 3.52% in BS + BC group and 2.61% in BC group, yet there was no *Phyllobacterium* detected in the 3 replicates of either BS or CK group. *Plesiomonas* (accounting for 6.08% and 2.72% of the reads in CK and BS groups) was present in the CK and BS groups; however, this genus was found at lower levels in the BS + BC and BC groups (0.4% in BS + BC group and 0.14% in BC group). *Escherichia*-*Shigella* (accounting for 0.16% of the reads) was detected in the CK group, and with probiotic treatment a larger amount of *Escherichia*-*Shigella* was detected (7.54% in BS group, 2.37% in BS + BC group and 4.22% in BC group). However, there were no significant differences in *Phyllobacterium*, *Plesiomonas* and *Escherichia*-*Shigella* after ANOVA of every group, due to high individual variability ([Appendix Fig. 1](#appsec1){ref-type="sec"}). After the cessation of probiotic supplementation plus 7 d of basal diet feeding, reads of *Rhizobium* in the BS-7D group increased on average from 0.32% (BS) to 43.57%, but *Cetobacterium* dropped from 73.53% (BS) to 21.13%. However, *Rhizobium* and *Cetobacterium* in the BS + BC and BC groups both had smaller changes after the cessation of probiotic supplementation.Fig. 6Heatmap of the 30 most predominant genus among all gut samples. CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5; BS-7D group: the BS group after cessation of probiotic consumption for 1 wk; BS + BC-7D group: the BS + BC group after cessation of probiotic consumption for 1 wk; BC-7D group: the BC group after cessation of probiotic consumption for 1 wk.Fig. 6

At the species level, *Bacillus licheniformis*, *Bacteroides* sp., *Rhizobium radiobacter*, Ambiguous taxa, and Unclassified were the main components. Further, a larger fraction of *R. radiobacter*, which belong to the α-Proteobacteria, was detected in the BC and BS + BC groups than in the CK group ([Appendix Fig. 2](#appsec1){ref-type="sec"}).

3.6. Statistical analysis of metagenomic profiles {#sec3.6}
-------------------------------------------------

The linear discriminate analysis (LDA) effect size (LEfSe), which is a statistical instrument developed for locating biomarkers in the metagenome, was used with default parameters for identifying possible discriminating taxa among groups. In this research, statistical analysis was only conducted on a phylum-to-genus level.

In total, 14 distinguishing taxa were detected between the groups of BS and CK with LDA scores both over 3 ([Fig. 7](#fig7){ref-type="fig"}A). One phylum (Firmicutes), 1 class (Bacilli), 1 order (Lactobacillales), 1 family and 2 genera were statistically higher in *B. subtilis*-treated fish. However, in the CK group, there was 1 phylum (Fusobacteria), 2 classes (Fusobacteria and Bacteroidia), 2 orders (Fusobacteriales, and Bacteroidales), 2 families and 1 genus that were enriched. The cladogram shows the 34 distinguishing taxa from the CK and BS + BC groups (LDA score \> 3) ([Fig. 7](#fig7){ref-type="fig"}B). Compared to the CK group, 1 phylum (Proteobacteria), 2 classes (α- and β-Proteobacteria), 5 orders (Franklales, Rickettsiales, Sphingomonadales Burkholderiales and Rhizobiales), 6 families and 8 genera all had larger amounts in the BS + BC group. However, the amounts of 2 phyla (Fusobacteria and Bacteroidetes), 2 classes (Bacteroidia and Fusobacteria), 2 orders (Bacteroidales and Fusobacteriales), 3 families and 3 genera were greater in the CK group. In total, there were 42 obviously distinguishing taxa between the CK and BC groups ([Fig. 7](#fig7){ref-type="fig"}C). On the phylum level, the BC group clearly had a greater number of Proteobacteria compared to the CK group. In addition, in comparison, the CK group had enriched reads of Fusobacteria, Actinobacteria and Bacteroidetes.Fig. 7Cladograms indicating the polygenetic distribution of bacterial lineages associated with different groups of samples. CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5. Indicators between the CK and probiotic-fed groups with an linear discriminate analysis (LDA) score larger than 3, with red circles representing those bacteria richer in CK group samples, and green circles representing those richer in samples of BS (A), BS + BC (B) and BC (C) groups, respectively.Fig. 7

The BS group had richer *Escherichia-Shigella* and *Weissella* reads compared to the CK group, while reads from *Cetobacterium* were obviously richer in the CK group in comparison with the BS group at the genus level. The reads of *Methylobacterium*, *Phyllobacterium*, *Rhizobium* and *Escherichia-Shigella* were enriched in the BS + BC and BC groups compared to the CK group. However, the CK group had more enriched *Plesiomonas* and *Cetobacterium* reads compared to the BS + BC and BC groups. In comparison with the CK group, the BC group had more prevalent *Bacillus* sp., and the most enriched *Bacillus* OTU (54 OTU) shared a sequence identity of 100% with *B. licheniformis*.

As shown in [Appendix Fig. 3](#appsec1){ref-type="sec"}, after cessation of probiotic administration for 1 wk, *Weissella*, *Cetobacterium* and *Bosea* were enriched in the BS group compared to the BS-7D group, but *Phyllobacterium*, *Rhizobium* and *Achromobacter* were significantly enriched in the BS-7D group compared to the BS group, which was under successive probiotic feeding. Reads of *Achromobacter* were enriched in the BS + BC-7D and BC-7D groups compared to the BS + BC and BC groups, respectively. However, *Nakamurella* was enriched in the BC + BC group compared to the BS + BC-7D group.

4. Discussion {#sec4}
=============

The growth and feed utilization of juvenile Nile tilapia was improved by supplementation of combined *B. subtilis* and *B. cereus* or *B. cereus* by itself. Similar to the results of this study, tilapia growth performance has been improved by the use of *Lactobacillus plantarum* and *B. subtilis* or a mixture of *Saccharomyces cerevisiae*, *L. plantarum* and *B. subtilis* ([@bib14]). After feeding for 4 to 8 wk, the weight gain of Nile tilapia was significantly increased in the *Bacillus pumilus* and the commercial probiotic product Organic Green (Hangpoong Industry Co. Ltd, Korea) supplementation groups in comparison to the CK group ([@bib8]). In addition, when the fish feed, which contained 40% or 27% crude protein, was supplemented with combined or single probiotics, it was more conducive to improving WG and FCR in comparison to the basal diet ([@bib25]). After a 10-wk feeding trial, growth rather than FCR of tilapia was promoted by dietary *B. licheniformis* ([@bib20]). However, there were no positive effects of some probiotic strains on Nile tilapia growth performance in other studies. After a 21-d growth trial, the growth performance of tilapia in a *B. subtilis* strain-amended diet group was similar to that of the control group ([@bib1]). According to an observation of tilapia fed with *B. subtilis*- and Previda-supplemented feed for 8 wk, the growth performance of these fish did not significantly change ([@bib2]). *Bacillus amyloliquefaciens* at a concentration of 1 × 10^4^ CFU/g was not significantly effective in improving tilapia growth performance after 30 d of feeding, but it promoted the growth of fish at the end of 60 d ([@bib43]). The different antibiosis activities of probiotics, together with the different interactions among the intestinal beneficial bacteria, probiotics, feed, host and research conditions have led to the observed distinguishing effects of probiotics on the growth performance of Nile tilapia. These differences can consequently influence probiotic effects on growth performance in other studies. In this study, the single *B. subtilis* diet had no effect on tilapia WG and FCR. However, BS + BC and BC treatments positively affected the WG and FCR of these fish.

It has been reported that a multispecies (*Pediococcus acidilactici*, *Enterococcus faecium*, *B. subtilis* and *Lactobacillus reuteri*) probiotic-amended diet significantly increased tilapia mid-intestinal microvilli density in 8 wk ([@bib39]). The numerical increases of microvilli length and perimeter ratio (PR, internal perimeter of the intestine lumen to external perimeter of the intestine ratio) suggest that intestinal morphology is improved by probiotic administration ([@bib39]). The improved length and density of the mid-intestinal microvilli may indicate the increased intestinal absorptive surface area from the application of probiotics ([@bib50]). Further, the higher microvilli density may be more conducive to the enhancement of tilapia resistance to possible pathogens by reducing the extent to which the interenterocyte junctions are exposed. In this research, supplementation with probiotics significantly increased microvillus length and density in the mid-intestine, which was consistent with previously obtained results regarding tilapia ([@bib39]). These results indicate the improvement effect of *B. subtilis* and *B. cereus* on the health condition of the intestines. The increased length and density of mid-intestinal microvilli may be one of the reasons for enhanced resistance to disease, utilization of feed and performance in growth of tilapia within the BS + BC and BC groups in this study.

This study showed a higher *lyzc* gene expression in the mid-intestines of tilapia fed a probiotic-supplemented diet than those in the control group. Previous studies showed that the c-type lysozymes of tilapia were effective in lysing both Gram-negative and Gram-positive strains ([@bib17]). The tilapia could recognize the bacterial challenges, generate an acute stress, and enhance body immunity by secreting specific proteins such as lysozymes ([@bib17]). Lysozymes can break down the cytoderm of bacteria by hydrolyzing the chemical bonds between N-acetylglucosamine and N-acetylmuramic acid. Therefore, lysozymes are capable of lysing specific Gram-positive and even several Gram-negative strains ([@bib5]). Previously, a study demonstrated the significant effect of dietary *Bacillus* spp. on increasing lysozyme levels in Nile tilapia, which resulted in a high rate of survival after challenge with *Edwardsiella tarda* ([@bib54]). Changes in the leukocyte population in the process of immune response development can be reflected in variations of lysozyme levels. A higher level of lysozymes detected in the probiotic-fed tilapia may serve as an indicator showing their improved immunity ([@bib48]). In a previous study, enhanced nonspecific defense systems and enhanced resistance ability to *Streptococcus iniae* by feeding dietary *B. licheniformis*-supplemented feed were reported in Nile tilapia ([@bib20]). In this research, similar results were observed in tilapia fed with combined *B. subtilis* and *B. cereus* or *B. cereus* alone when challenged with *S*. *agalactiae*.

Strong adherence to the inner facets of the intestines (mucus and mucosa), which has been shown to be of great importance for beneficial activities, is one criterion for probiotic strain selection ([@bib11], [@bib34]). As suggested in other studies, probiotics that combined unstably with the gut mucosal zone may release rapidly when suspended, bringing about dysbiosis of intestinal strains as well as ensuing disorders, and finally leading to an increased chance of infection ([@bib32]). In this research, during probiotic administration, the probiotics were not located in the gastrointestinal mucosal zone of tilapia, which indicated that these probiotics could not adhere to the intestinal mucosa and proliferate. This finding showed the challenge of successfully colonizing the fish gut with a probiotic strain. The persistence of probiotics in the gut is species-specific ([@bib51]), and the dosage and duration of supplementation and the selection of probiotic strain(s) might influence colonization success, while the persistence of the probiotic might also depend on the developmental state of the animal ([@bib37], [@bib41], [@bib18]). However, the gut microbiota developed significant differences between treatments (except between the BS and CK groups), and the composition of the gut microbiota remained stable 1 wk after cessation of the administration of the probiotics, which means that discontinuation of probiotic administration (except for the BS group) did not cause significant fluctuations in gut microbes. In this study, potential probiotics, such as *Rhizobium* sp., which belong to the phylum Proteobacteria, were the major strains detected in tilapia intestines from the BS + BC and BC groups but were rarely found (\<1%) in the CK and BS groups. Generally, many enzymes with pectolytic and cellulolytic activities were produced by *Rhizobium* bacteria and have the ability to hydrolyze the glycosidic skeleton in the cytoderm of plant cells ([@bib24], [@bib45]). *Rhizobium* live as endosymbionts in some phytophagous insect intestines and are helpful with the synthesis of nitrogen-containing substances that are generally insufficient in the food of the host insects ([@bib47]). In this study, the coenzyme Q10 producing bacteria *R. radiobacter* was the most common *Rhizobium* species and may function to improve immunity ([@bib4], [@bib59]). Changes in the autochthonous gut bacterial community and the increase in some beneficial bacteria in the intestines may be related to the improved resistance to diseases, utilization of feed and performance in growth of tilapia within the BS + BC and BC groups.

The use of combined *B. subtilis* and *B. cereus* or *B. cereus* by itself decreased the distribution of *Plesiomonas* and *Cetobacterium* and increased the distribution of *Phyllobacterium* and *Escherichia-Shigella* in the tilapia intestine. Operational taxonomic units of *Plesiomonas* and *Cetobacterium* were found in the intestinal tract of tilapia, forming the core microbiome, which were quite stable and resistant in response to dietary treatments ([@bib3]). The genus *Plesiomonas* was also found within the intestines of tilapia that were cultured in earthen ponds ([@bib36]), and it is considered to be a conditional pathogen in aquaculture systems. *Plesiomonas* is a pathogen for goldfish ([@bib61]) and grass carp ([@bib23]). *Plesiomonas* is more prevalent in sick gibel carp than in healthy gibel carp, acting as a conditional pathogen in gibel carp ([@bib49]). One possible way to use probiotics and prebiotics to reduce infection of hosts is by restoring intestinal microbial diversity ([@bib49], [@bib56]). *Cetobacterium* was the most abundant genus (82.15%) in control fish intestines, and this genus has previously been isolated from other fish intestines (including tilapia) ([@bib3], [@bib26], [@bib51]). *Cetobacterium* was the most dominant species in both sick fish that were infected by *Cyprinid herpesvirus* 2 (CyHV-2) and in healthy fish ([@bib36]). *Phyllobacterium* sp. is a slow-growing, N-2-fixing bacterium ([@bib46]) that has the ability to degrade organic matter and remove nitrogen and phosphorus from sludge particles ([@bib62]). *Phyllobacterium* bacteria were specific to the intestines of both the BS + BC and BC groups in this study. *Escherichia-Shigella* is a common pathogen of aquatic animals and can cause disease, such as diarrhea, ascites and sepsis, in aquatic animals ([@bib53]). Although there is no significant difference between the groups due to the existence of individual differences, the impact of *Escherichia-Shigella* in this study needs to be further explored. The metagenomics and metatranscriptomics of the intestinal bacteria should be investigated in future studies to reveal the functionality and contribution to improved immunity and growth performance of the tilapia fed the combination of *B. subtilis* and *B. cereus* or *B. cereus* alone.

5. Conclusions {#sec5}
==============

The *B. subtilis* and *B. cereus*- or *B. cereus*-supplemented fish feeds at 1 × 10^8^ CFU/g are capable of promoting growth, improving feed utilization and morphology of the intestine, enhancing intestinal *lyzc* expression and disease resistance, and altering the intestinal microbiota composition of tilapia. In future studies, further investigations are required to determine the effects of the probiotic-induced gastrointestinal microbiota on immune responses and growth performance in tilapia. Interesting new lines of research may someday arise from gnotobiotic fish, microbial engineering and metabonomics.
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[^1]: One kilogram of vitamin premix contained the following: thiamine, 0.438 g; riboflavin, 0.632 g; pyridoxine·HCl, 0.908 g; D-pantothenic acid, 1.724 g; nicotinic acid, 4.583 g; biotin, 0.211 g; folic acid, 0.549 g; vitamin B~12~, 0.001 g; inositol, 21.053 g; menadione sodium bisulfite, 0.889 g; retinyl acetate, 0.677 g; cholecalciferol, 0.116 g; DL-α-tocopherol-acetate, 12.632 g.

[^2]: One kilogram of mineral premix contained the following: CoCl~2~·6H~2~O, 0.074 g; CuSO~4~·5H~2~O, 2.5 g; FeSO~4~·7H~2~O, 73.2 g; NaCl, 40.0 g; MgSO~4~·7H~2~O, 284.0 g; MnSO~4~·H~2~O, 6.50 g; KI, 0.68 g; Na~2~SeO~3~, 0.10 g; ZnSO~4~·7H~2~O, 131.93 g; cellulose, 501.09 g.

[^3]: IBW = initial body weight; WG = weight gain; FCR = feed conversion ratio; SR = survival rate.

[^4]: ^a,\ b^Within a row, means with different letter superscripts are significantly different (*P* \< 0.05).

[^5]: Data represent means ± standard deviation (*n* = 6 fish).

[^6]: CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *B. subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *B. cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5.

[^7]: ^a,\ b,\ c^Within a row, means with different letter superscripts are significantly different (*P* \< 0.05).

[^8]: Data represent means ± standard deviation (*n* = 6 fish).

[^9]: CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *B. subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *B. cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5.

[^10]: ^a,\ b,\ c^Within a column, means with different letter superscripts are significantly different (*P* \< 0.05).

[^11]: Data represent means ± standard deviation (*n* = 3 fish).

[^12]: CK group: the basal diet; BS group: the basal diet with 1 × 10^8^ CFU/g of *Bacillus subtilis*; BS + BC group: the basal diet with both 0.5 × 10^8^ CFU/g of *B. subtilis* and *Bacillus cereus* NY5; BC group: the basal diet with 1 × 10^8^ CFU/g of *B. cereus* NY5; BS-7D group: the BS group after cessation of probiotic consumption for 1 wk; BS + BC-7D group: the BS + BC group after cessation of probiotic consumption for 1 wk; BC-7D group: the BC group after cessation of probiotic consumption for 1 wk.
